STUART M BARNES
Allopathic & Osteopathic Physicians|Internal Medicine ANDERSON, SC NPI 1114106325
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine SC Lilly USA, LLC All categories
General Payments — all program years on this page
$4,065.59
- Category: General Payments
- Program years: PY2018–2023
- Record count: 249
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $1,105.35 across 63 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,105.35 | 63 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $286.61 | 17 |
| Lundbeck LLC | $88.55 | 3 |
| Novo Nordisk AS | $81.05 | 5 |
| Acerta Pharma LLC | $79.67 | 4 |
| PFIZER INC. | $78.01 | 5 |
| Bayer HealthCare Pharmaceuticals Inc. | $71.88 | 4 |
| IDORSIA PHARMACEUTICALS US INC | $62.56 | 4 |
| ABBVIE INC. | $51.50 | 3 |
| GlaxoSmithKline, LLC. | $47.95 | 3 |
| DEXCOM, INC. | $47.33 | 3 |
| Janssen Pharmaceuticals, Inc | $34.42 | 2 |
| Teva Pharmaceuticals USA, Inc. | $34.39 | 2 |
| Antares Pharma, Inc. | $19.55 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.52 | 1 |
| Amneal Pharmaceuticals LLC | $18.32 | 1 |
| Halozyme Inc | $17.43 | 1 |
| SANOFI-AVENTIS U.S. LLC | $17.19 | 1 |
| Xeris Pharmaceuticals, Inc. | $17.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.80 | 1 |
| Amgen Inc. | $15.62 | 1 |
By program year
Records — PY2023 (63)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.